Medtronic Plc (MDT) Shareholder Gateway Investment Advisers LLC Lifted Holding by $9.83 Million as Valuation Declined

April 17, 2018 - By Marguerite Chambers

Medtronic plc (NYSE:MDT) LogoInvestors sentiment decreased to 1.02 in 2017 Q4. Its down 0.10, from 1.12 in 2017Q3. It dived, as 65 investors sold MDT shares while 427 reduced holdings. 111 funds opened positions while 393 raised stakes. 1.04 billion shares or 2.98% less from 1.07 billion shares in 2017Q3 were reported. Knott David M has invested 0.03% in Medtronic plc (NYSE:MDT). Florida-based Naples Global Advisors Lc has invested 0.59% in Medtronic plc (NYSE:MDT). Douglass Winthrop Advisors Limited Co has 4,475 shares. Trillium Asset Management stated it has 181,399 shares or 0.81% of all its holdings. Violich Mngmt Inc, California-based fund reported 28,580 shares. National Bank Of Nova Scotia has 0.17% invested in Medtronic plc (NYSE:MDT). Highlander Mgmt Limited Liability invested 0.67% of its portfolio in Medtronic plc (NYSE:MDT). Regentatlantic Limited Liability Corp holds 15,498 shares or 0.1% of its portfolio. Advantus Capital Mgmt reported 0.27% of its portfolio in Medtronic plc (NYSE:MDT). First Amer Savings Bank accumulated 55,062 shares. Carnegie Cap Asset Ltd holds 6,513 shares or 0.05% of its portfolio. 929,851 were reported by Ci Investments. Greenleaf holds 4,426 shares. 2,711 are held by Logan Cap Mngmt. Fred Alger Mgmt reported 1.06M shares.

Gateway Investment Advisers Llc increased its stake in Medtronic Plc (MDT) by 12.29% based on its latest 2017Q4 regulatory filing with the SEC. Gateway Investment Advisers Llc bought 122,848 shares as the company’s stock declined 4.15% with the market. The institutional investor held 1.12 million shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q4, valued at $90.63M, up from 999,551 at the end of the previous reported quarter. Gateway Investment Advisers Llc who had been investing in Medtronic Plc for a number of months, seems to be bullish on the $109.26 billion market cap company. The stock increased 0.01% or $0.01 during the last trading session, reaching $80.61. About 1.38M shares traded. Medtronic plc (NYSE:MDT) has declined 3.54% since April 17, 2017 and is downtrending. It has underperformed by 15.09% the S&P500.

Gateway Investment Advisers Llc, which manages about $12.58B and $11.77 billion US Long portfolio, decreased its stake in Express Scripts Hldg Co (NASDAQ:ESRX) by 77,566 shares to 437,191 shares, valued at $32.63M in 2017Q4, according to the filing. It also reduced its holding in Kimberly Clark Corp (NYSE:KMB) by 152,433 shares in the quarter, leaving it with 22,643 shares, and cut its stake in Parker Hannifin Corp (NYSE:PH).

Medtronic plc (NYSE:MDT) Ratings Coverage

Among 10 analysts covering Medtronic (NYSE:MDT), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. Medtronic has $99.0 highest and $85.0 lowest target. $92.83’s average target is 15.16% above currents $80.61 stock price. Medtronic had 13 analyst reports since November 10, 2017 according to SRatingsIntel. Stifel Nicolaus maintained it with “Hold” rating and $85.0 target in Wednesday, November 22 report. The rating was upgraded by Argus Research to “Buy” on Tuesday, December 12. The stock has “Buy” rating by Bank of America on Tuesday, January 2. The rating was maintained by BMO Capital Markets with “Buy” on Tuesday, December 12. Needham maintained the shares of MDT in report on Tuesday, November 21 with “Buy” rating. On Thursday, March 29 the stock rating was maintained by Morgan Stanley with “Equal-Weight”. The firm has “Buy” rating by Needham given on Wednesday, February 21. The firm earned “Buy” rating on Friday, November 17 by SunTrust. On Thursday, February 22 the stock rating was maintained by Citigroup with “Buy”. The firm has “Buy” rating given on Tuesday, November 21 by Jefferies.

Medtronic plc (NYSE:MDT) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: